1. Home
  2. PRPO vs AIMD Comparison

PRPO vs AIMD Comparison

Compare PRPO & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • AIMD
  • Stock Information
  • Founded
  • PRPO N/A
  • AIMD 1984
  • Country
  • PRPO United States
  • AIMD United States
  • Employees
  • PRPO N/A
  • AIMD N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPO Industrials
  • AIMD Health Care
  • Exchange
  • PRPO Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • PRPO N/A
  • AIMD 11.9M
  • IPO Year
  • PRPO N/A
  • AIMD N/A
  • Fundamental
  • Price
  • PRPO $16.27
  • AIMD $3.11
  • Analyst Decision
  • PRPO
  • AIMD
  • Analyst Count
  • PRPO 0
  • AIMD 0
  • Target Price
  • PRPO N/A
  • AIMD N/A
  • AVG Volume (30 Days)
  • PRPO 13.9K
  • AIMD 75.7K
  • Earning Date
  • PRPO 08-12-2025
  • AIMD 08-04-2025
  • Dividend Yield
  • PRPO N/A
  • AIMD N/A
  • EPS Growth
  • PRPO N/A
  • AIMD N/A
  • EPS
  • PRPO N/A
  • AIMD N/A
  • Revenue
  • PRPO $20,029,000.00
  • AIMD $106,207.00
  • Revenue This Year
  • PRPO N/A
  • AIMD N/A
  • Revenue Next Year
  • PRPO N/A
  • AIMD N/A
  • P/E Ratio
  • PRPO N/A
  • AIMD N/A
  • Revenue Growth
  • PRPO 26.67
  • AIMD 13.38
  • 52 Week Low
  • PRPO $3.90
  • AIMD $2.00
  • 52 Week High
  • PRPO $16.50
  • AIMD $5.00
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 82.13
  • AIMD 57.16
  • Support Level
  • PRPO $10.60
  • AIMD $3.07
  • Resistance Level
  • PRPO $11.70
  • AIMD $3.34
  • Average True Range (ATR)
  • PRPO 0.86
  • AIMD 0.24
  • MACD
  • PRPO 0.43
  • AIMD 0.07
  • Stochastic Oscillator
  • PRPO 93.06
  • AIMD 79.73

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: